KEGG   DRUG: Depemokimab
Entry
D12169                      Drug                                   
Name
Depemokimab (USAN);
Depemokimab (genetical recombination) (JAN)
Formula
C6474H10108N1734O2025S44
Exact mass
145952.8990
Mol weight
146042.88
Sequence
(Heavy chain)
QVTLRESGPA LVKPTQTLTL TCTVSGFSLT GSSVHWVRQP PGKGLEWLGV IWASGGTDYN
SALMSRLSIS KDTSRNQVVL TMTNMDPVDT ATYYCARDPP SGLLRLDYWG RGTLVTVSSA
STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKRVEPK SCDKTHTCPP CPAPELLGGP
SVFLFPPKPK DTLYITREPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
(Light chain)
DIVMTQSPDS LAVSLGERAT INCKSSQSLL NSGNQKNYLA WYQQKPGQPP KLLIYGASTR
ESGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCQNVHSF PFTFGGGTKL EIKRTVAAPS
VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
(Disulfide bridge: H22-H95, H146-H202, H222-L220, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'95, H'146-H'202, H'222-L'220, H'263-H'323, H'369-H'427, L23-L94, L140-L200, L'23-L'94, L'140-L'200)
  Type
Peptide
Class
Immunological agent
 DG02019  Interleukin inhibitor
Efficacy
Antiasthmatic, Anti-IL-5 antibody
  Type
Monoclonal antibody
Target
IL5 [HSA:3567] [KO:K05428]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  JAK-STAT signaling pathway
Brite
Drug groups [BR:br08330]
 Immunological agent
  DG02019  Interleukin inhibitor
   D12169  Depemokimab
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Interleukins
    IL5
     D12169  Depemokimab (USAN)
Other DBs
CAS: 2243274-14-6
PubChem: 497620582
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system